Buy Provigil Online

About two-thirds of travellers report having jetlag. Symptoms of jet-lag include daytime tiredness, difficulty initiating sleep at night (after eastward flight) or early awakening (after westward flight), disturbed night-time sleep, impaired daytime alertness and performance, gastrointestinal problems, loss of appetite, and inappropriate timing of defecation and urination.

Such symptoms can seriously impair a person’s performance and ability to function, in part because of the reduction in sleep quality and quantity, and because performance and alertness rhythms will take several days to resynchronise. In the long-term (eg, after 4 years), chronic disruption of circadian rhythms from regular transmeridian travel might result in cognitive deficits (decreased short-term memory, slower reaction time) and changed physiological parameters (such as cortisol concentrations).

Because of their rapidly changing and conflicting light-dark exposure and activity-rest behaviour, shiftworkers can have symptoms similar to those of jetlag. Although travellers normally adapt to the new time zone, shift-workers usually live out of phase with local time cues.

Read more …

“Half of the clinical studies of potential pharmacologic interventions to prevent olanzapine-associated weight gain have been negative, at huge expense. We hope that this approach will help identify drugs with a better chance of working,” lead investigator James L. Roerig, PharmD, from the University of North Dakota School of Medicine, in Fargo, told Medscape Psychiatry.

The method developed by Dr. Roerig and colleagues uses brief placebo-controlled trials with normal volunteers to determine whether a prospective treatment drug deserves study in clinical trials.

The process starts with a brief trial to show that the main treatment agent will produce the target adverse effect in normal volunteers; it is followed by a short placebo-controlled study to see whether adding the candidate drug reduces the adverse effect enough in normal volunteers to signal that the test drug is likely to work and deserves further study.

Read more …

Provigil appears to be unlike classic stimulants. We investigated this generality by testing the selectivity of this compound for wake-promoting effects (e.g., relative to locomotor effects) and homeostatic sleep responses after drug-induced waking relative to the prototypical stimulant methamphetamine (METH).

Continuous measures of electroencephalogram (EEG) sleep-wakefulness, locomotor activity (LMA) and body temperature (Tb) were obtained from adult male Wistar rats 3 days before and after treatment with Provigil (30, 100 and 300 mg/kg i.p.), 0.25% methylcellulose (vehicle) or METH (0.5 and 1.0 mg/kg i.p.). Individually housed rats in a 24-h light-dark cycle (LD 12:12) were treated 5 h after lights-on (CT-5).

LMA and Tb were monitored via intraperitoneal telemetry. Sleep-wake stages and LMA were recorded every 10 s, Tb every minute. During the first 3 h post-treatment, Provigil and METH significantly and dose-dependently increased EEG wake time (P < .01 for 30 mg/kg Provigil, all other P < .0001) and wake episode duration.

Read more …

Narcolepsy is caused by the loss of orexin-containing neurons in the hypothalamus, and a novel nonstimulant wakefulness-promoting drug, Provigil, alleviates excessive day-time sleepiness associated with the disorder.

The level of arousal is controlled by an intricate interplay between distinct wakefulness – and sleep-promoting nuclei situated in the hypothalamus and brainstem and the interconnections between the nuclei and the neurotransmitters involved have been mapped.

Read more …